Paul Tudor Jones's NVAX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 128,859 shares of Novavax, Inc. (NVAX) worth $1.05 M, representing 0.00% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in NVAX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 128,859 shares. Largest reduction occurred in Q1 2023, reducing 46,624 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Novavax (NVAX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novavax (NVAX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +128,859 | New Buy | 128,859 | $8.14 |
| Q2 2024 | -37,030 | Sold Out | 0 | $0.00 |
| Q1 2024 | +37,030 | New Buy | 37,030 | $4.78 |
| Q3 2023 | -12,289 | Sold Out | 0 | $0.00 |
| Q2 2023 | +12,289 | New Buy | 12,289 | $7.43 |
| Q1 2023 | -46,624 | Sold Out | 0 | $0.00 |
| Q4 2022 | +7,694 | Add 19.76% | 46,624 | $0.01 |
| Q3 2022 | -27,221 | Reduce 41.15% | 38,930 | $18.21 |
| Q2 2022 | +18,886 | Add 39.96% | 66,151 | $51.43 |
| Q1 2022 | +43,374 | Add 1114.73% | 47,265 | $73.65 |
| Q4 2021 | -5,218 | Reduce 57.28% | 3,891 | $143.15 |
| Q3 2021 | -324 | Reduce 3.43% | 9,109 | $207.27 |
| Q2 2021 | +9,433 | New Buy | 9,433 | $212.34 |
Paul Tudor Jones's Novavax Investment FAQs
Paul Tudor Jones first purchased Novavax, Inc. (NVAX) in Q2 2021, acquiring 9,433 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Novavax, Inc. (NVAX) for 13 quarters since Q2 2021.
Paul Tudor Jones's largest addition to Novavax, Inc. (NVAX) was in Q1 2026, adding 128,859 shares worth $1.05 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 128,859 shares of Novavax, Inc. (NVAX), valued at approximately $1.05 M.
As of the Q1 2026 filing, Novavax, Inc. (NVAX) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Novavax, Inc. (NVAX) was 128,859 shares, as reported at the end of Q1 2026.